SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending significantly due to positive FDA feedback, confirming no additional clinical trials are required for their lead drug sonelokimab in hidradenitis suppurativa, clearing its regulatory path. The community is actively discussing this de-risking event as a major catalyst, fueling speculation about a potential buyout by big pharma and a return to much higher price levels.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending after releasing preliminary Q4 results alongside cautious 2026 and 2027 revenue guidance for DefenCath, primarily due to anticipated changes in reimbursement. This news, coupled with recent insider share sales, has triggered a significant price decline, though many in the community perceive it as an overreaction and a buying opportunity for an undervalued stock. Despite strong recent financial performance, investors are actively debating management's long-term strategy and potential future dilution from acquisitions.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as its stock experiences a notable downturn, prompting community discussion about its "oversold" status and a perceived lag in AI innovation compared to surging tech peers. Investors are closely watching for an upcoming Supreme Court decision on tariffs and a potential rebound, with many anticipating strong future earnings to reverse the stock's recent divergence from overall market strength.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is a key trending stock following a strong earnings report that surpassed revenue and profitability estimates, fueled by rapid expansion in high-performance computing. Community discussion centers on the company's substantial data center pipeline, including advanced talks for new hyperscaler capacity, which could significantly boost contracted revenue and put pressure on short positions within the booming AI infrastructure sector.

iPower, Inc. engages in the online retail and supply of consumer home, garden, in-home farming, pet, and wellbeing products. It sells its brands such as Simple Deluxe, YSSOA, Zenhydro, Flourish, iPOWER, iFarm, FluffyDream, ScratchMe, and HealSmart through zenhydro.com, simpledeluxe.com, and various third-party online platforms. The company offers grow light systems, advanced heating, ventilation and air conditioning (HVAC) systems, water pumps, heaters, chillers and filters, nutrient and fertilizer delivery systems, and various growing media typically made from soil, rock wool or coconut fiber. It also provides home goods supplies including commercial fans, floor and wall fans, storage and shelving units, and chairs. The company was founded by Chenlong Tan and Allan Huang on April 11, 2018 and is headquartered in Rancho Cucamonga, CA.

iPower Inc

IPW is trending following its initial investment in Bitcoin and Ethereum as part of a new Digital Asset Treasury strategy, signaling a strategic pivot into digital assets. The community is actively discussing the stock's extremely low float and surging trading volume, fueling speculation for a potential short squeeze and significant upward movement, with many keenly watching for sustained gains.

flyExclusive, Inc. engages in owning and operating jet aircraft for private jet passengers. It manages all aspects of the customer experience, in-house maintenance, repair, and overhaul services, including paint, interiors, and avionics capabilities. The company was founded by Thomas James Segrave, Jr. in 2015 and is headquartered in Kinston, NC.

flyExclusive Inc. - Ordinary Shares - Class A

FLYX is experiencing significant trading activity after announcing its role as an authorized Starlink Aviation dealer, integrating high-speed connectivity into its private jet services. The community is actively discussing the low float and potential for a short squeeze, with many anticipating a substantial move while others caution about profit-taking and volatility. This news positions the company at the forefront of in-flight innovation within the private aviation sector, driving widespread interest.

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Aclarion Inc

Aclarion Inc. (ACON) is trending after providing an upbeat corporate outlook, highlighting accelerating Nociscan AI platform adoption and a strong, debt-free balance sheet. The community is actively discussing the stock's exceptionally low float and substantial cash per share, igniting widespread speculation for a significant short squeeze. Investors are optimistic about its AI-driven healthcare solution and anticipate further upside as clinical trials progress.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

MannKind is actively discussed after recent business updates highlighted a record-setting fourth quarter revenue, fueling optimism among investors. This, combined with a recent pediatric regulatory clearance for FUROSCIX and the ongoing launch of Afrezza in India, has propelled the stock to new 52-week highs. The community is buzzing with bullish analyst upgrades and increased speculation surrounding deeper collaboration or potential acquisition interest from its key partner, United Therapeutics, given strong platform performance.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is generating significant buzz following its planned integration of NVIDIA's AI computing module into future aircraft and its participation in the White House's eVTOL Integration Pilot Program. The community is actively discussing the stock's immediate upside potential to break key resistance levels, alongside its long-term prospects in urban air mobility and strategic defense applications. While some express caution, many anticipate further positive movement as the company advances toward critical certification milestones and expands its operational footprint.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

U.S.-China Trade Tensions Stiffen: ETF Areas Likely to Lose the Most

As U.S.-China trade tensions intensify again, ETFs like SMH, XLK, TSLT, BJK, XRT, RTH, LGHT, and USO are likely to come under pressure.

Semiconductor stocks have had a volatile week with the back-and-forth between President-elect Donald Trump and the Chinese government on tariffs and sanctions.&nbsp;The Philadelphia Semiconductor Index (SOX) fell by over 5.7% in the previous session, and was down as much as 2% in pre-market trading on Friday.Stocktwits’ exclusive retail activity analysis shows that shares of Applied Materials, ACM Research, Aehr Test Systems, Universal Display Corporation, and Microchip Technology saw the biggest surge in retail chatter over the last 24 hours.Here’s how retail is feeling about the chip manufacturing stocks:Applied Materials Inc.<figure class="image"><img style="aspect-ratio:1291/304;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_06_064738_a0e1107083.png" alt="Screenshot 2024-12-06 064738.png" width="1291" height="304"><figcaption>Applied Materials Sentiment and Message Volume on Dec 6 as of 6:45 a.m. ET | Source: Stocktwits.</figcaption></figure><a href="https://stocktwits.com/symbol/AMAT">Shares of Applied Materials</a> saw a modest 0.4% uptick in pre-market trading on Friday, after clocking a 5% drop in the previous session after Morgan Stanley downgraded the stock citing concerns around the company’s target market.The brokerage downgraded the stock to ‘Underweight’ from ‘Equal Weight’ and cut its price target to $164 from $179.Retail sentiment around the stock remained bearish (38/100) even as chatter rose to ‘high’ before markets opened on Friday.&nbsp;According to Stocktwits data, Applied Materials experienced a 620% surge in message volume over the past 24 hours, building on its 12-fold increase in conversational activity over the past week.The stock has only gained 11.4% so far this year after the stock hit an all-time high in July, resulting in massive profit booking.&nbsp;ACM Research Inc.<figure class="image"><img style="aspect-ratio:1287/291;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_06_064818_3224bf0137.png" alt="Screenshot 2024-12-06 064818.png" width="1287" height="291"><figcaption>ACM Research Sentiment and Message Volume on Dec 6 as of 7:00 a.m. ET | Source: Stocktwits.</figcaption></figure>Shares of ACM Research saw a sharp turnaround in pre-market trading on Friday. The stock was up as much as 3% after a massive tumble of nearly 15% in the previous session causing the stock to hit over one year lows of $13.87.The drop came after Craig-Hallum downgraded the stock to ‘Hold’ from ‘Buy’ and slashed its price target to $18 from $30.The brokerage pointed out that ACM Research’s operating subsidiaries were recently added to the&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-stock-drops-us-tightens-control-on-china-chip-exports/cJ9kmCRRhb">U.S. export restriction list</a>, creating more uncertainty about the potential effects on the company.Retail sentiment around the stock, however,&nbsp;has jumped three levels to ‘extremely bullish’ (93/100) from ‘bearish’ a day ago with message volume hitting the ‘extremely high’ zone. Chatter indicates that retail investors are capitalizing on the opportunity to buy-the-dip.According to Stocktwits data, ACM Research registered a 615% increase in message count over the last 24 hours.The stock saw the highest uptick in chatter this week, second only to Marvell Technology, with a 92x increase.Aehr Test Systems Inc.<figure class="image"><img style="aspect-ratio:1293/306;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_06_050721_6d67f04803.png" alt="Screenshot 2024-12-06 050721.png" width="1293" height="306"><figcaption>Aehr Test Systems Sentiment and Message Volume on Dec 6 as of 7:15 a.m. ET | Source: Stocktwits.</figcaption></figure>Shares of Aehr Test Systems jumped as much as 2% in pre-market trading on Friday, after recording a 7% drop in the previous session.&nbsp;The stock has been struggling to gain since it decreased its revenue outlook for fiscal 2023 in January and subsequently reported a 25% fall in revenue YoY for the full year.&nbsp;Wall Street sees challenges in customer orders and market conditions challenging the company in the near-term, with the company’s revenue falling another 21% sequentially in the August quarter.Retail sentiment around Aehr dipped to ‘bearish’ (33/100) from ‘neutral’ a day&nbsp;ago as more people joined the conversation, pushing message volumes to ‘extremely high’.&nbsp;According to Stocktwits data, the ticker saw a 260% increase in message count over the last 24 hours.&nbsp;Aehr’s stock value has halved so far this year with worries of weakening demand and delayed orders weighing on the shares.For updates and corrections email newsroom[at]stocktwits[dot]com.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/canadian-solar-stock-tumbles-on-q3-2024-earnings-miss/cJ9Afe2RLW">Canadian Solar Stock Tumbles On Q3 Earnings Miss: Retail Keeps Faith</a>

Representative image of a semiconductor (Credit: Pixabay)

Applied Materials, ACM Research, Aehr Test See Retail Chatter Surge Before Friday’s Open

ACM Research’s stock has had a 92x increase in chatter over the last 7 days, the highest among semiconductor stocks, second only to Marvell Technology. 

AMAT, ACMR, AEHR Lead Semiconductor Stocks In Retail Chatter Surge Ahead of Friday’s Market Open

Equity

ACM Research’s stock has had a 92x increase in chatter over the last 7 days, the highest among semiconductor stocks, second only to Marvell Technology. 


Taiwan Semiconductor Manufacturing Company (TSM) on Thursday announced an upbeat set of second quarter earnings that topped analyst estimates led by an increasing demand for chips used in artificial intelligence (AI) applications. TSM reported a 40.10% jump in net sales at New Taiwan Dollar (NT) 673.51 billion as compared to a Street estimate of NT657.58. Net income came in at NT247.85 billion as compared to an estimate of NT238.80 billion.<figure class="image"><img style="aspect-ratio:789/223;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_18_at_8_43_21_AM_e0365a2377.png" alt="Retail sentiment remains bearish for TSM stock" width="789" height="223"><figcaption>Retail sentiment remains bearish for TSM stock despite upbeat second quarter earnings</figcaption></figure>Despite the better-than-expected earnings, retail sentiment remained in bearish territory (40/100) on Stocktwits supported by extremely high message volumes (93/100) that hit a one-year high. Some users are concerned the positive earnings report may not be enough for the stock to hold on to the significant gains it is sitting on.Moreover, a report that indicated the US may be considering tough trade restrictions on semiconductor companies had led to a sell-off in chip stocks on Wednesday – something that could be preventing retail from being overly bullish on the sector.TSM said in dollar terms, second quarter revenue stood at $20.82 billion, up 32.80% year-over-year.Wendell Huang, Senior VP and Chief Financial Officer at TSMC said that the second quarter was supported by strong demand for its 3 nanometer and 5 nanometer technologies, partially offset by continued smartphone seasonality.During the second quarter, shipments of 3-nanometer accounted for 15% of total wafer revenue. Meanwhile, 5-nanometer accounted for 35% of the revenue and 7-nanometer accounted for 17%. Advanced technologies, defined as 7-nanometer and more advanced technologies, accounted for 67% of total wafer revenue.“Moving into third quarter 2024, we expect our business to be supported by strong smartphone and AI-related demand for our leading-edge process technologies,” Huang said.For the third quarter, the company expects its revenue to come in between $22.40 billion and $23.20 billion. This tops an earlier Street estimate of $22.60 billion.Based on the exchange rate assumption of one dollar to 32.50 NT dollars, it expects a gross profit margin between 53.50% and 55.50% and an operating profit margin between 42.50% and 44.50%.Shares of the firm have risen over 68% since the beginning of the year to $171.20. Recently, Needham reportedly raised its price target on the stock to $210 from the earlier target of $168 and maintained a ‘Buy’ rating on the stock. &nbsp;

TSM Second Quarter Earnings Beat Analyst Estimates: Here’s How Retail Reacted

Despite the better-than-expected earnings, retail sentiment remained in the bearish territory (40/100) on Stocktwits supported by extremely high message volumes (93/100) that hit a one-year high.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X Shares

Physical AI Infrastructure

Power & Energy to Support Growth

Healthcare Value & Innovation

Other – Comment Below

As markets head into 2026, investors are debating whether the next phase favors speculation or real-world execution. With capital rotating toward infrastructure, energy, and undervalued sectors like healthcare, which area do you think will matter most for portfolios in the year ahead?

Which Theme Will Matter Most for Portfolios in 2026?

Current Price	$2.63
Prev Close	$2.45
Open	$2.49
Dividend Yield	N/A
50-Day Moving Average	$3.37
Beta	N/A
Avg. Volume	303.88M
PE Ratio	N/A

52-Week High	$53.43
52-Week Low	$2.37
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

SOXS
Direxion Daily Semiconductor Bear 3X Shares

Feed

News

Sentiment

Fundamentals

Info

Latest SOXS News

SOXSDirexion Daily Semiconductor Bear 3X Shares